Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
about
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
description
im Mai 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 March 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2018
@uk
name
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@en
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@nl
type
label
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@en
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@nl
prefLabel
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@en
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@nl
P2093
P1476
Contrast-Enhanced Spectral Mam ...... g Neoadjuvant Systemic Therapy
@en
P2093
Barbara A Pockaj
Bhavika K Patel
Donald W Northfelt
Heidi E Kosiorek
Marc Lobbes
Matthew Covington
P304
P356
10.1245/S10434-018-6413-X
P407
P50
P577
2018-03-07T00:00:00Z